Development of a new tissue regeneration technology using human adipose-derived stem cell

Development of a new tissue regeneration technology using human adipose-derived stem cell - AdSC technique

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1090220126

Enrollment

Registered

2013-05-31

Start date

2013-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients underwent prostate resection surgery

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients underwent prostate resection surgery

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
efficiency of the differentiation method of cardiomyocytes and other types of cells	—

Secondary

Measure	Time frame
Evaluation of the differentiated cells which are transplantes into mice.	—

Countries

Japan

Contacts

Public ContactJunko Nakahira

Osaka Medical College

ane052@poh.osaka-med.ac.jp+81-72-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026